TLDR: A highly technical biotech mini-conference about shaking incubator technology for growing mammalian cells, covering oxygen transfer rates, vessel geometry, and cell cultivation -- way over the author's head but attended with good humor and a free laptop bag.

TLDR: Kelly attends a pharma industry awards dinner and grows suspicious of the event's design -- excessive wine, emotionally heavy speeches about rare diseases, and an award recipient who thanks his FDA "wording team" -- questioning whether the setup is engineered to manufacture compliance.

TLDR: A lunch-and-learn on aging research featuring a scientist studying frailty in mice, covering topics like sex differences in aging, biomarkers, cloning, metabolomics, and the discovery that anti-aging compounds may exist in mushrooms and even bugs.

TLDR: Detailed notes from a life-science startup conference featuring panelists who founded billion-dollar companies, covering conviction to start, fundraising strategies, grant writing, AI in drug discovery, and advice for female founders in biotech.

TLDR: A webinar workshop led by an experienced NIH grant reviewer covering SBIR/STTR funding phases, applicant eligibility, team building, budgeting basics (including the flexible 7% profit rule), and how tailoring every detail of your application to evaluation criteria can make or break your score.

TLDR: A lunch-and-learn panel on how biotech and pharma companies can strategically share clinical trial data without crossing into insider trading territory, covering blackout periods, SEC/FINRA compliance, selective disclosure rules, and the importance of documenting who knows what and when.